Haleon (HLN) Minority Interest (2021 - 2026)

Haleon's (HLN) quarterly Minority Interest came in at $80.5 million in Q2 2026, up 1.84% on a QoQ basis from $79.0 million in Q4 2025.

Haleon (HLN) Minority Interest (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Minority Interest data on file, last reported at $80.5 million in Q2 2026.

Quarterly Minority Interest changed N/A year-over-year to $80.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $80.5 million (changed N/A YoY) and the FY2025 annual result came in at $78.5 million, up 5.85% from the prior year.
Minority Interest climbed to $80.5 million in Q2 2026, from $79.0 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $152.7 million in Q4 2023 to a low of $74.4 million in Q4 2024.
A 5-year average of $118.4 million and a median of $133.0 million in 2022 frame the typical range for Minority Interest.
Annual changes were most pronounced in 2023 — Minority Interest grew 11.79% — and 2024, when it tumbled 51.24%.
Tracing HLN's Minority Interest over 5 years: stood at $147.8 million in 2022, then advanced by 3.3% to $152.7 million in 2023, then plunged by 51.24% to $74.4 million in 2024, then rose by 6.19% to $79.0 million in 2025, then advanced by 1.84% to $80.5 million in 2026.
The last three Minority Interest figures came in at $80.5 million (Q2 2026), $79.0 million (Q4 2025), and $74.4 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Alkermes	8.02 Bn	7.37 Bn	397.90 Mn

Download Data